Washington, D.C.—Senator Ron Wyden (D-OR) urged FDA to promptly issue guidance that ensures the regulatory pathway Congress intended for the lawful use of CBD...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
